Valiant Laboratories IPO listing price is ₹ 169.05, issue price is ₹ 140.00, and currently trading at ₹ 113.81 as on June 26, 2025. Valiant Laboratories IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Valiant Laboratories IPO is a Book Building listing on BSE,NSE exchange. The company is based in Mumbai and caters to Pharmaceutical sector. Unistone Capital is the merchant banker of Valiant Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 5th June 2023.
Valiant Laboratories IPO offer price is ₹ 140.00 and got listed at ₹ 169.05. Read Valiant Laboratories IPO details mentioned above.The IPO of Valiant Laboratories Limited was listed on 6th October 2023. As of today, Valiant Laboratories IPO is trading at ₹ 113.81, compared to the previous day’s close of ₹ 116.34. Read the report above for detailed IPO performance.
The issue price of Valiant Laboratories IPO was ₹ 140.00 per equity share.
Valiant Laboratories IPO was listed at ₹169.05 on the stock exchange on 6th October 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 26, 2025, the current market price of Valiant Laboratories IPO is ₹ 113.81.
The 52-week high for Valiant Laboratories IPO is ₹ 157.49, while the 52-week low is ₹ 75.20. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Valiant Laboratories IPO listed at ₹ 169.05 against the issue price of ₹ 140.00 per equity share, showing a listing day gain/loss of 29.05 (20.75%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Valiant Laboratories IPO stock moved from its listing price of ₹ 169.05 to the current price of ₹113.81 per equity share, reflecting a change of -32.68% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Valiant Laboratories IPO issue date of 6th October 2023 and CMP of ₹113.81, the estimated CAGR is approximately -11.29%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Valiant Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Valiant Laboratories Financial Review Page
Merchant Banker(s) of Valiant Laboratories IPO: Unistone Capital Private Limited
Valiant Laboratories IPO subscription was 29.76 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Valiant Laboratories IPO listed at a listing price of 169.05 against the offer price of 140.00.
The current market price of Valiant Laboratories is 113.81.
Why Us?